enGene Therapeutics Inc. ENGN
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.04% | -6.34% | 42.44% | -4.05% | -7.12% |
| Total Receivables | -1.61% | -20.96% | 66.01% | 214.10% | 33.02% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.03% | -10.10% | 77.55% | -37.93% | -13.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.33% | 1.35% | -6.33% | 9.72% | 0.00% |
| Total Current Assets | 2.93% | -6.64% | 43.61% | -4.69% | -7.31% |
|
|
|||||
| Total Current Assets | 2.93% | -6.64% | 43.61% | -4.69% | -7.31% |
| Net Property, Plant & Equipment | -4.31% | -4.75% | -2.77% | 3.50% | 208.42% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.02% | -0.72% | 1.69% | -1.23% | 0.29% |
| Total Assets | -6.24% | -8.78% | 52.22% | -9.81% | -7.91% |
|
|
|||||
| Total Accounts Payable | 41.72% | -26.37% | -63.59% | 180.54% | 52.14% |
| Total Accrued Expenses | 32.57% | -16.36% | 32.43% | 47.68% | -14.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.29% | -1.04% | -74.98% | 44.34% | 73.43% |
| Total Finance Division Other Current Liabilities | -30.22% | 317.98% | -61.74% | -49.36% | 40.79% |
| Total Other Current Liabilities | -30.22% | 317.98% | -61.74% | -49.36% | 40.79% |
| Total Current Liabilities | 26.64% | -12.69% | -23.05% | 56.45% | 13.55% |
|
|
|||||
| Total Current Liabilities | 26.64% | -12.69% | -23.05% | 56.45% | 13.55% |
| Long-Term Debt | 0.98% | 0.70% | 61.42% | -13.45% | -11.57% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.92% | -4.19% | -3.61% | -4.11% | 403.89% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.84% | -5.78% | 3.37% | 19.79% | 14.02% |
|
|
|||||
| Common Stock & APIC | 1.14% | 0.61% | 26.55% | 0.86% | 0.49% |
| Retained Earnings | -7.52% | -7.52% | -8.00% | -11.34% | -9.50% |
| Treasury Stock & Other | -18.40% | -35.51% | 5.18% | 26.55% | -24.77% |
| Total Common Equity | -9.75% | -9.37% | 67.88% | -16.43% | -11.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.75% | -9.37% | 67.88% | -16.43% | -11.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.75% | -9.37% | 67.88% | -16.43% | -11.71% |
|
|
|||||